Topic Highlight Open Access
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jan 7, 2014; 20(1): 37-44
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.37
Gastrointestinal motility disorders in inflammatory bowel diseases
Gabrio Bassotti, Elisabetta Antonelli, Gastroenterology and Hepatology Section, Department of Clinical and Experimental Medicine, University of Perugia, 06156 Perugia, Italy
Vincenzo Villanacci, Marianna Salemme, Second Pathology Section, Spedali Civili of Brescia, 25100 Brescia, Italy
Manuela Coppola, Vito Annese, Gastroenterology Unit, Careggi University Hospital, 50134 Florence, Italy
Author contributions: Bassotti G and Annese V ideated the project; Bassotti G wrote the first draft of the manuscript; Antonelli E, Villanacci V, Salemme M, Coppola M and Annese V critically reviewed the manuscript; all authors read and approved the final version of the manuscript.
Correspondence to: Gabrio Bassotti, Professor, Gastroenterology and Hepatology Section, Department of Clinical and Experimental Medicine, University of Perugia, Ospedale Santa Maria della Misericordia, Piazzale Menghini 1, 06156 Perugia, Italy. gabassot@tin.it
Telephone: +39-75-5784423 Fax: +39-75-5847570
Received: July 18, 2013
Revised: September 16, 2013
Accepted: September 29, 2013
Published online: January 7, 2014

Abstract

The relationship between motility and inflammatory gastrointestinal disorders is at the same time complex and intriguing since these conditions might share some genetic, environmental, immunological and microbial predisposing factors. In addition, significant symptom overlapping may occur, muddling the waters within the clinical context. Although on one hand this represents a challenge for the clinician for a potential under- or over-treatment and diagnostic delay, on the other hand it possibly represents an opportunity for the researcher to better disclose the intimate relationship between chronic (often low-grade) inflammation, motor disorders and deranged sensory function. The best example is probably represented by Crohn’s disease and ulcerative colitis. In fact, a number of gastrointestinal motor disorders have been described in association with these diseases, disorders which span from the esophagus to the anorectum, and which will be extensively covered in this review. It is conceivable that at least part of this derangement is strictly related to inflammatory cytokine trafficking and neuromuscular changes; however, given the high prevalence of functional gastrointestinal disorders in the general population, this overlap might also be serendipitous. However, it is worth noting that literature data on this topic are relatively scarce, sometimes quite outdated, and mostly focused on the interplay between irritable bowel syndrome and inflammatory bowel disease. Nevertheless, both researchers and clinicians must be aware that symptoms related to gastrointestinal motility disorders may be highly prevalent in both active and inactive inflammatory bowel disease, correlate with greater psychological comorbidity and poorer quality of life, and may negatively influence the therapeutic approaches.

Key Words: Crohn’s disease, Gastrointestinal motility disorders, Gut, Inflammatory bowel diseases, Perception, Ulcerative colitis

Core tip: Gastrointestinal motor disorders are not infrequently associated with inflammatory bowel disease and may represent a confounding factor, especially when inflammation has subsided or the clinical picture is in remission. Since these entities may involve all the segments of the gastrointestinal tract, it is important that clinicians and researchers be aware of this potential overlap, since lack of knowledge may lead to mistreatment or overtreatment. However, literature data on this topic are relatively scarce and are extensively covered in this review.



INTRODUCTION

Inflammatory bowel diseases (IBD), mainly represented by Crohn’s disease (CD) and ulcerative colitis (UC), are emerging pathological conditions whose epidemiological rising is thought to be related to the westernization of lifestyle and industrialization[1]. The genesis of IBD is quite complex and numerous pathophysiological factors are now recognized to be involved in the predisposition, triggering, progression and outcome of these conditions[2].

Interestingly, several of these factors are the same thought to be responsible for the genesis of (at least some of) gastrointestinal motor abnormalities, disorders that are classified among the so-called functional gastrointestinal disorders[3], i.e., those pathological entities in which no known structural (pathological or radiological) abnormalities, infectious or metabolic causes are present[4]. However, in recent years it has become evident that, at least for some of these entities, the pathophysiological mechanisms, defined as “idiopathic” until now, can actually be reconducted to some form (sometimes very subtle) of low grade inflammation. This is, for instance, the case of esophageal achalasia[5,6], functional dyspepsia[7,8], irritable bowel syndrome (IBS)[9] and chronic constipation[10,11], where the presence of limited number of inflammatory cells infiltrating the mucosa and/or the myenteric plexus has been reported. On the other hand, the recent description of enteric nervous system (ENS) abnormalities in IBD patients (mainly represented by myenteric plexitis)[12,13] may justify alterations of the normal motor function and visceral reflexes of the gut.

Thus, as we will see below, the co-existence of IBD and gastrointestinal motor disorders may somewhat represent more than a serendipitous occasion and it is likely that motility and/or perception abnormalities play a role in the clinical pictures of IBD, sometimes complicating the physician’s assessment and the patient’s lifestyle. To what extent these motor abnormalities provoke or correlate with gastrointestinal symptoms reported by IBD patients during remission is rather unknown. However, despite potential limitations, the majority of studies report a greater frequency of “IBS-like” symptoms in quiescent IBD compared to the background population[14].

GENERAL CONSIDERATIONS

The relationship between gastrointestinal motility disorders and IBD is a quite complex one and not well elucidated yet since multiple variables appear to play a role. For instance, IBS-like symptoms are frequently found in patients with IBD considered to be in clinical remission and it is very difficult to distinguish these symptoms as due to IBS or to persisting occult inflammation[15]. Moreover, symptoms related to motility/functional gastrointestinal disorders are highly prevalent in both active and inactive IBD and correlate with greater psychological comorbidity and poorer quality of life[16,17]. Some data also suggest that intercurrent infectious gastroenteritis may increase IBD risk in IBS patients[18]. However, as can be seen from the literature evidence, most data on the relationship of functional gastrointestinal disorders/IBD is actually focused on the relationship of IBS/IBD and the other gastrointestinal motor abnormalities are relatively neglected. The following paragraphs will take into consideration these relationships for each segment of the gastrointestinal tract (Table 1).

Table 1 Summary of motor abnormalities and gastrointestinal symptoms in inflammatory bowel diseases patients in each segment of the gastrointestinal tract.
SegmentMotor changesSymptomsRef.
EsophagusAspecific, achalasia-like (rare)Gastroesophageal reflux[18,19,24,25]
StomachDelayed emptyingNot reported (?)[30,31,34,35]
Biliary treePossible reduction of cyclic contractions of gallbladder due to deranged phase III and motilin peaksSymptoms related to gallstones[41,42]
Small bowelLarge amplitude, rapidly propagated waves in small bowel of UC after proctocolectomyIBS-like symptoms[49,57-60]
Reduced small bowel contractions, increased incidence single and clustered propagated contractions in CD[63,64]
ColonDecreased contractility in UC with accelerated transitDiarrhea[75-77]
Reduced tone after meals[80]
Increased propulsive activity[81]
AnorectumLow anal pressure, poor rectal distensibility, reduced compliance, enhanced perceptionIncontinence, urgency[84-88]
[90-93]
[94,95]
ESOPHAGUS

Although relatively uncommon (about 5%-8% in both adults and children[19,20]), esophageal involvement has become increasingly recognized in IBD, especially in patients with CD[21], even in the absence of specific symptoms as patients more frequently undergo upper endoscopical evaluations[22]. The clinical manifestations are usually due to the mucosal and/or transmural involvement by the inflammatory process. One report showed an achalasia-like motility disorder in a patient with dysphagia and CD, with the esophageal dysmotility being due to the extensive inflammatory/fibrotic process[23]. To date, no specific clinical or manometric investigations have been carried out in IBD patients, except a small group of UC patients undergoing esophageal manometry as a pathological control group[24] in whom no abnormalities were found compared with normal controls.

It is worth noting that gastro-esophageal reflux symptoms are more frequent in patients with active IBD compared with those with quiescent disease[25] and are associated with a reduced quality of life and increasing likelihood of anxiety and depression compared to controls [26].

STOMACH

Upper gastrointestinal involvement in IBD patients may be found in about 15%-20% of patients[27,28]. However, subtle microscopical abnormalities of the stomach and duodenum may be also present in patients with IBD and might explain some upper gastrointestinal symptoms[29]. However, to date, only a few studies have investigated gastric motor function in patients with IBD. An earlier study with barium meal (a suboptimal method to evaluate gastric motor activity) on three patients with gastric involvement showed loss of normal gastric motility[30]. A subsequent scintigraphic study on pediatric patients showed that gastric emptying was normal in UC patients and delayed in about 30% of children with CD[31]. This delay was more prominent in malnourished children[32]. The scintigraphic findings of normal gastric emptying in UC adults have been confirmed by other authors[33]. Gastric emptying after intestinal resection in adults with CD proved to be within normal limits and the authors concluded that the diarrhea observed in these subjects should not be attributed to rapid gastric emptying[34]. In a scintigraphic study on gastric emptying in adult patients with non-obstructive CD and no upper gastrointestinal involvement, we showed that, compared with healthy volunteers, no overall significant differences were found; however, subgroup analysis revealed that symptomatic patients and those with colonic involvement had a significantly delayed gastric emptying compared to controls. Such a difference was also observed between symptomatic and asymptomatic patients[35]. Another scintigraphic study investigated the occurrence and putative pathophysiological mechanisms of gastric motor disorders in a small group of adult IBD patients and concluded that disturbances of gastric emptying are most pronounced in CD and might partly be caused by excessive CCK release[36].

BILIARY TREE

Although the hepatobiliary tree is frequently affected in patients with IBD[37], its motor function has been scarcely investigated in these subjects and only a few data are available in the literature. An ultrasound study carried out in a small group of IBD patients during continuous enteral nutrition revealed that gallbladder contractility and responsiveness to intravenous cholecystokinin are preserved in such instances[38]. Another ultrasound study reported that after ileo-cecal resection, fasting gallbladder volume is decreased, whereas postprandial gallbladder motility is normal[39]. Cholecystectomy specimens from patients with IBD did not show significant histopathological differences compared to controls[40]. Nevertheless, gallstone prevalence is increased in CD patients; site and duration of disease and previous intestinal resections are considered as risk factors, even although data are conflicting[41]. In 25 asymptomatic, uncomplicated CD patients we found a significant derangement of phase III of migrating motor complex in terms of occurrence, cycling and origination from the antro-duodenal region. Moreover, no clear peaking of motilin before phase III was found[42]. Therefore, we hypothesized that in some patients with CD, a reduction of cyclic phasic contractions of gallbladder occurs because of a decreased incidence of motilin peaks and phases III of the migrating motor complex in the antro-duodenal area. Thus, the lack of periodic stirring of bile contained in the gallbladder may lead to supersaturation and stone formation[43].

SMALL BOWEL

The small bowel represents the main anatomic site of involvement for patients with CD, even although the terminal ileum may be rarely involved in UC[44]. In vitro studies showed that inflammation impairs the contractile responses of human small intestine[45] and this may be observed even with minimal inflammatory responses[46].

Thus, IBD patients may complain of symptoms not only related to the active phases of their disease, but also to low grade inflammation that produces symptoms correlated to autonomic dysfunction and abnormalities of the motor activity or of visceral sensations[47]. These symptoms are associated with lower quality of life and higher healthcare utilization in IBD patients and may herald a cohort at risk for worse outcomes[48] since they may be present even in patients with quiescent disease, in whom the quality of life may be severely impaired by this association[49,50]. In addition, in these patients a potential overtreatment with drug-related toxicity might occur. On the above grounds, it is therefore not surprising that a substantial number of IBD patients experience IBS-type symptoms (abdominal pain and discomfort, diarrhea, constipation)[14], symptoms that often originate from low-grade inflammation causing abnormal motility and perception, especially (but not only) in the small intestine[51]. These patients exhibit similar pathophysiological features to people diagnosed with IBS in the general community[52-54], suggesting that the conditions are not mutually exclusive, may coexist in a considerable number of IBD patients[55], and that clinical indexes may be insufficient to discriminate between the two conditions[56]. Fortunately, the availability of fecal markers of inflammation may be quite useful in this setting[57]. However, it should be kept in mind that a certain number of IBD patients with normal fecal calprotectin levels experience IBS-type symptoms and exhibit similar features to people diagnosed with IBS in the general community, suggesting that the conditions are not mutually exclusive and may coexist in a considerable number of IBD patients[55].

Concerning objective measurements, it is worth noting that, notwithstanding the frequent involvement, the small bowel motor function (due to the relatively invasive manometric techniques needing deep intestinal intubation and prolonged periods of recordings) has been scarcely investigated in IBD.

UC

The few available studies have been conducted on the small bowel of patients after proctocolectomy and ileal pouch-anal anastomosis. In a manometric study on eight such patients, the authors concluded that jejunoileal motility is not greatly altered by this kind of surgery. However, the appearance of large amplitude, rapidly propagating waves in the proximal jejunoileum after operation may be a response to increased storage within and distention of the distal bowel[58]. Subsequently, similar findings (also by electromyographic assessment) have been reported by other authors[59-61]. Interestingly, the defunctionalized ileum in these patients is able to regain at least some of its motor function after a brief period of meal stimulation[62].

CD

In a study conducted on nine patients with partial mechanical obstruction due to CD, jejunal manometry showed that after the meal the most striking finding was the regular occurrence of clustered contractions. The associated periods of quiescent motor activity may account for the unexpectedly reduced postprandial frequency and motility index in obstructed patients compared with normal subjects[63]. Another manometric study, carried out in CD patients without any sign of occlusion receiving total parenteral nutrition for acute exacerbation of the disease, showed that after correction of nutritional status and clinical improvement, jejunal motility is almost normal in most patients, although some abnormalities (mainly affecting the interdigestive motor complexes) may be documented in a few subjects[64]. In a manometric study on fasting and postprandial gastroduodenal motor activity carried out in 35 patients with inactive CD[65], we observed abnormal motility aspects in 74% of these patients and concluded that most patients with inactive, uncomplicated CD display marked gastrointestinal motor disorders, characterized either by reduced incidence of small bowel contractions and increased incidence of single or clustered propagated contractions.

LARGE BOWEL

Since this viscus is the most frequently affected target in UC, it is not surprising that (also due to its relatively easier access), concerning motility and perception, the researchers’ interest has focused more on the colon than on the other hollow viscera. Indeed, there is wide experimental evidence that inflammation may affect the motor[66-69] and perceptive[70-72] function of the large bowel. Interestingly, these effects are observed after resolution of the inflammatory phenomena[73] and might be related to the fact that, at least for a subset of patients, a complete mucosal healing is not (or never) reached[74] and a persistent subclinical inflammation associated with increased colonic paracellular permeability may be associated with the presence of IBS-like symptoms[75]. It is also worth noting that the role of inflammation is not limited to the mucosa and muscular components of the bowel wall, but also involves the neuroenteric circuitries (i.e., the ENS)[12,13,76].

Early manometric studies carried out in the rectosigmoid area revealed decreased colonic contractility in patients with UC[77,78] and correlated this decrease with the presence of diarrhea[79], findings also confirmed by myoelectric techniques[80]. Subsequently, the simultaneous assessment of motility and transit in UC patients carried out by a combined manometric/scintigraphic approach confirmed that the reduced colonic motor activity is also present in more proximal segments and that these patients have increased propagated activity of the colon that may speed the transit of contents[81]. Moreover, it has been demonstrated by studies conducted with the barostat that UC patients display reduced tone of the descending colon following meals[82]. More recent studies evaluating 24 h manometric recordings of colonic motility in patients with UC showed that, compared to controls, patients with moderately active disease have increased propulsive activity (of both high and low amplitude), a mechanism likely to be responsible for the diarrhea[83]. This mechanism may be related to the distension of the large bowel[84] due to accumulation of fluids and inflammatory materials. Interestingly, the increased number of high-amplitude propagated contractions reduces in UC patients in remission, whereas the low-amplitude propulsive activity remains higher compared to controls, possibly contributing to the persistence of abdominal symptoms in a subgroup of patients[85].

ANORECTUM
CD

Anorectal manometric variables and rectal sensation have been reported to be abnormal in CD patients, even in those with only microscopic involvement[86-89]. In particular, low pressures due to anal involvement are strongly correlated with fecal incontinence[90]. Other authors, however, were unable to correlate urgency with anorectal variables or sensation[91]. It is worth noting that poor rectal distensibility may predict a worse outcome of ileorectal anastomosis[92].

UC

The frequency and urgency of defecation and the fecal incontinence in these patients may be due to a hypersensitive, hyperactive and poorly compliant rectum[93-95]. In patients with active disease, no abnormalities of the sphincter functions are present, whereas perception to stimuli appears altered compared to controls[96,97].

Postoperative conditions

Anorectal manometry can predict the early outcome after closure of a diverting ileostomy in patients with ileorectal anastomosis since it has been shown that the number of bowel movements after surgery strongly correlated with the anal pressure and the neorectal compliance[98]. This technique also helped to elucidate better the effects of surgery; in fact, prolonged manometric examination showed that the internal anal sphincter is damaged in the course of mucosal proctectomy and endoanal anastomosis, whereas after restorative proctocolectomy with stapled, end-to-end anastomosis a normal function of the internal sphincter is preserved[99]. Of note, it has been shown that preservation of the rectoanal inhibitory reflex correlated with a decrease in the incidence of nocturnal soiling after confectioning of a double-stapled ileoanal reservoir[100]. Thus, several authors have relied on functional assessment to tailor the surgical reconstructive approach in UC patients[101-105].

CONCLUSION

Although relatively frequent, the co-presence of gastrointestinal motility abnormalities in IBD patients is still relatively unexplored. In fact, looking at the literature data, it is evident that only a few studies are available and most of the more recent literature is focused on the relationship of IBS/IBD[106]. Thus, information on this topic is still scarce, especially concerning the upper gut. In addition, no controlled data are available regarding the response to treatment of motility changes and/or functional symptoms in IBD.

Moreover, little information is available on whether these motor abnormalities may influence delivery of drugs within the gut in IBD patients since most studies on this topic have been carried out in healthy volunteers. However, some patient data suggest that an increased gastrointestinal transit might impair absorption of several mesalazine formulations[107]. An accelerated transit might also modify the release of budesonide or multi matrix formulation compounds, but data are lacking[108]. Finally, some literature data suggest that abnormalities of rectal wall motility might increase mesalazine absorption in IBD patients with ileorectal anastomosis compared to controls[109].

Hopefully, with the rising interest in the role of low grade inflammation as an important pathophysiological factor in the genesis of several gastrointestinal disorders[110], more information will be available on the role of neuroimmune interactions leading to symptoms that may complicate the clinical picture in patients with IBD, especially when the major flares of disease are resolved.

Footnotes

P- Reviewer: Beales ILP S- Editor: Wen LL L- Editor: Roemmele A E- Editor: Liu XM

References
1.  Ng SC, Bernstein CN, Vatn MH, Lakatos PL, Loftus EV, Tysk C, O’Morain C, Moum B, Colombel JF. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630-649.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 378]  [Cited by in F6Publishing: 403]  [Article Influence: 36.6]  [Reference Citation Analysis (0)]
2.  Fiocchi C. Genes and ‘in-vironment’: how will our concepts on the pathophysiology of inflammatory bowel disease develop in the future? Dig Dis. 2012;30 Suppl 3:2-11.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 21]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
3.  Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-1390.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology. 1987;92:1282-1284.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Bruley des Varannes S, Chevalier J, Pimont S, Le Neel JC, Klotz M, Schafer KH, Galmiche JP, Neunlist M. Serum from achalasia patients alters neurochemical coding in the myenteric plexus and nitric oxide mediated motor response in normal human fundus. Gut. 2006;55:319-326.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Villanacci V, Annese V, Cuttitta A, Fisogni S, Scaramuzzi G, De Santo E, Corazzi N, Bassotti G. An immunohistochemical study of the myenteric plexus in idiopathic achalasia. J Clin Gastroenterol. 2010;44:407-410.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 37]  [Article Influence: 2.6]  [Reference Citation Analysis (0)]
7.  Kindt S, Tertychnyy A, de Hertogh G, Geboes K, Tack J. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil. 2009;21:832-e56.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 84]  [Cited by in F6Publishing: 91]  [Article Influence: 6.1]  [Reference Citation Analysis (0)]
8.  Walker MM, Salehian SS, Murray CE, Rajendran A, Hoare JM, Negus R, Powell N, Talley NJ. Implications of eosinophilia in the normal duodenal biopsy - an association with allergy and functional dyspepsia. Aliment Pharmacol Ther. 2010;31:1229-1236.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 111]  [Cited by in F6Publishing: 84]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
9.  Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163-173.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 399]  [Cited by in F6Publishing: 370]  [Article Influence: 26.4]  [Reference Citation Analysis (0)]
10.  Bassotti G, Villanacci V, Maurer CA, Fisogni S, Di Fabio F, Cadei M, Morelli A, Panagiotis T, Cathomas G, Salerni B. The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut. 2006;55:41-46.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Manenti S, Antonelli E, Fanini L, Salerni B. Increase of colonic mast cells in obstructed defecation and their relationship with enteric glia. Dig Dis Sci. 2012;57:65-71.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 19]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
12.  Villanacci V, Bassotti G, Nascimbeni R, Antonelli E, Cadei M, Fisogni S, Salerni B, Geboes K. Enteric nervous system abnormalities in inflammatory bowel diseases. Neurogastroenterol Motil. 2008;20:1009-1016.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 117]  [Cited by in F6Publishing: 118]  [Article Influence: 7.4]  [Reference Citation Analysis (0)]
13.  Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Fisogni S, Antonelli E, Corazzi N, Salerni B. Enteric neuroglial apoptosis in inflammatory bowel diseases. J Crohns Colitis. 2009;3:264-270.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 24]  [Article Influence: 1.6]  [Reference Citation Analysis (1)]
14.  Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1474-1482.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 388]  [Cited by in F6Publishing: 402]  [Article Influence: 33.5]  [Reference Citation Analysis (0)]
15.  Keohane J, O’Mahony C, O’Mahony L, O’Mahony S, Quigley EM, Shanahan F. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol. 2010;105:1788, 1789-1794; quiz 1795.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 140]  [Cited by in F6Publishing: 167]  [Article Influence: 11.9]  [Reference Citation Analysis (0)]
16.  Bryant RV, van Langenberg DR, Holtmann GJ, Andrews JM. Functional gastrointestinal disorders in inflammatory bowel disease: impact on quality of life and psychological status. J Gastroenterol Hepatol. 2011;26:916-923.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 54]  [Article Influence: 4.2]  [Reference Citation Analysis (1)]
17.  Kim ES, Cho KB, Park KS, Jang BI, Kim KO, Jeon SW, Jung MK, Kim EY, Yang CH. Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: association with functional gastrointestinal disorders and mood disorders. J Clin Gastroenterol. 2013;47:e38-e44.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 34]  [Cited by in F6Publishing: 34]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
18.  Porter CK, Cash BD, Pimentel M, Akinseye A, Riddle MS. Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol. 2012;12:55.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Ramaswamy K, Jacobson K, Jevon G, Israel D. Esophageal Crohn disease in children: a clinical spectrum. J Pediatr Gastroenterol Nutr. 2003;36:454-458.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Lazarev M, Huang C, Bitton A, Cho JH, Duerr RH, McGovern DP, Proctor DD, Regueiro M, Rioux JD, Schumm PP. Relationship between proximal Crohn’s disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium. Am J Gastroenterol. 2013;108:106-112.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 114]  [Cited by in F6Publishing: 129]  [Article Influence: 11.7]  [Reference Citation Analysis (0)]
21.  Hummel TZ, ten Kate FJ, Reitsma JB, Benninga MA, Kindermann A. Additional value of upper GI tract endoscopy in the diagnostic assessment of childhood IBD. J Pediatr Gastroenterol Nutr. 2012;54:753-757.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 71]  [Article Influence: 5.9]  [Reference Citation Analysis (0)]
22.  Turner D, Griffiths AM. Esophageal, gastric, and duodenal manifestations of IBD and the role of upper endoscopy in IBD diagnosis. Curr Gastroenterol Rep. 2009;11:234-237.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Knoblauch C, Netzer P, Scheurer U, Seibold F. Dysphagia in Crohn’s disease: a diagnostic challenge. Dig Liver Dis. 2002;34:660-664.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Usai P, Bassotti G, Usai Satta P, Cherchi M, Plesa A, Boy F, Morelli A, Balestrieri A. Oesophageal motility in adult coeliac disease. Neurogastroenterol Motil. 1995;7:239-244.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Katz J, Shenkman A, Stavropoulos F, Melzer E. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 2003;9:34-40.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Barratt SM, Leeds JS, Robinson K, Shah PJ, Lobo AJ, McAlindon ME, Sanders DS. Reflux and irritable bowel syndrome are negative predictors of quality of life in coeliac disease and inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2011;23:159-165.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 54]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
27.  Annunziata ML, Caviglia R, Papparella LG, Cicala M. Upper gastrointestinal involvement of Crohn’s disease: a prospective study on the role of upper endoscopy in the diagnostic work-up. Dig Dis Sci. 2012;57:1618-1623.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 90]  [Cited by in F6Publishing: 88]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
28.  Zeng Z, Zhu Z, Yang Y, Ruan W, Peng X, Su Y, Peng L, Chen J, Yin Q, Zhao C. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J Gastroenterol Hepatol. 2013;28:1148-1153.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 108]  [Cited by in F6Publishing: 125]  [Article Influence: 11.4]  [Reference Citation Analysis (0)]
29.  Danelius M, Ost A, Lapidus AB. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa. Scand J Gastroenterol. 2009;44:441-445.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
30.  Madore P, Glay A, Kahn DS. Lesions of the gastrointestinal tract resembling regional enteritis--a granulomatous disease: a report of three cases. Can Med Assoc J. 1963;89:1165-1170.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Gryboski JD, Burger J, McCallum R, Lange R. Gastric emptying in childhood inflammatory bowel disease: nutritional and pathologic correlates. Am J Gastroenterol. 1992;87:1148-1153.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Grill BB, Lange R, Markowitz R, Hillemeier AC, McCallum RW, Gryboski JD. Delayed gastric emptying in children with Crohn’s disease. J Clin Gastroenterol. 1985;7:216-226.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Rao SS, Read NW. Gastrointestinal motility in patients with ulcerative colitis. Scand J Gastroenterol Suppl. 1990;172:22-28.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Dew MJ, Harries AD, Rhodes M, Rhodes J, Leach KG. Gastric emptying after intestinal resection in Crohn’s disease. Br J Surg. 1983;70:92-93.  [PubMed]  [DOI]  [Cited in This Article: ]
35.  Annese V, Bassotti G, Napolitano G, Frusciante V, Bruno M, Conoscitore P, Germani U, Morelli A, Andriulli A. Gastric emptying of solids in patients with nonobstructive Crohn’s disease is sometimes delayed. J Clin Gastroenterol. 1995;21:279-282.  [PubMed]  [DOI]  [Cited in This Article: ]
36.  Keller J, Beglinger C, Holst JJ, Andresen V, Layer P. Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol. 2009;297:G861-G868.  [PubMed]  [DOI]  [Cited in This Article: ]
37.  Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1598-1619.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 148]  [Cited by in F6Publishing: 140]  [Article Influence: 10.0]  [Reference Citation Analysis (0)]
38.  Ledeboer M, Masclee AA, Biemond I, Lamers CB. Gallbladder motility and cholecystokinin secretion during continuous enteral nutrition. Am J Gastroenterol. 1997;92:2274-2279.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Vu MK, Gielkens HA, van Hogezand RA, van Oostayen JA, Lamers CB, Masclee AA. Gallbladder motility in Crohn disease: influence of disease localization and bowel resection. Scand J Gastroenterol. 2000;35:1157-1162.  [PubMed]  [DOI]  [Cited in This Article: ]
40.  Lin J, Shen B, Lee HJ, Goldblum JR. Histopathological characterization of cholecystectomy specimens in patients with inflammatory bowel disease. J Crohns Colitis. 2012;6:895-899.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 10]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
41.  Hutchinson R, Tyrrell PN, Kumar D, Dunn JA, Li JK, Allan RN. Pathogenesis of gall stones in Crohn’s disease: an alternative explanation. Gut. 1994;35:94-97.  [PubMed]  [DOI]  [Cited in This Article: ]
42.  Annese V, Bassotti G, Napolitano G, Betti C, Perri F, Usai P, Morelli A, Andriulli A, Vantrappen G. Most patients with inactive crohns-disease have gastrointestinal motility disorders. Gastroenterology. 1993;104:A470.  [PubMed]  [DOI]  [Cited in This Article: ]
43.  Annese V, Vantrappen G. Gall stones in Crohn’s disease: another hypothesis. Gut. 1994;35:1676.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 14]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
44.  Rubenstein J, Sherif A, Appelman H, Chey WD. Ulcerative colitis associated enteritis: is ulcerative colitis always confined to the colon? J Clin Gastroenterol. 2004;38:46-51.  [PubMed]  [DOI]  [Cited in This Article: ]
45.  Al-Saffar A, Hellström PM. Contractile responses to natural tachykinins and selective tachykinin analogs in normal and inflamed ileal and colonic muscle. Scand J Gastroenterol. 2001;36:485-493.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Peuhkuri K, Vapaatalo H, Korpela R. Even low-grade inflammation impacts on small intestinal function. World J Gastroenterol. 2010;16:1057-1062.  [PubMed]  [DOI]  [Cited in This Article: ]
47.  Straub RH, Antoniou E, Zeuner M, Gross V, Schölmerich J, Andus T. Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn’s disease and ulcerative colitis. J Neuroimmunol. 1997;80:149-157.  [PubMed]  [DOI]  [Cited in This Article: ]
48.  Ananthakrishnan AN, Issa M, Barboi A, Jaradeh S, Zadvornova Y, Skaros S, Johnson K, Otterson MF, Binion DG. Impact of autonomic dysfunction on inflammatory bowel disease. J Clin Gastroenterol. 2010;44:272-279.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 20]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
49.  Farrokhyar F, Marshall JK, Easterbrook B, Irvine EJ. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis. 2006;12:38-46.  [PubMed]  [DOI]  [Cited in This Article: ]
50.  Jonefjäll B, Strid H, Ohman L, Svedlund J, Bergstedt A, Simren M. Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission. Neurogastroenterol Motil. 2013;25:756-e578.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 59]  [Article Influence: 5.4]  [Reference Citation Analysis (0)]
51.  Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303:G775-G785.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 239]  [Cited by in F6Publishing: 260]  [Article Influence: 21.7]  [Reference Citation Analysis (0)]
52.  Kellow JE, Eckersley GM, Jones M. Enteric and central contributions to intestinal dysmotility in irritable bowel syndrome. Dig Dis Sci. 1992;37:168-174.  [PubMed]  [DOI]  [Cited in This Article: ]
53.  Serra J, Villoria A, Azpiroz F, Lobo B, Santos J, Accarino A, Malagelada JR. Impaired intestinal gas propulsion in manometrically proven dysmotility and in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:401-406, e91-2.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 32]  [Article Influence: 2.3]  [Reference Citation Analysis (0)]
54.  Lee OY. Asian motility studies in irritable bowel syndrome. J Neurogastroenterol Motil. 2010;16:120-130.  [PubMed]  [DOI]  [Cited in This Article: ]
55.  Berrill JW, Green JT, Hood K, Campbell AK. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Aliment Pharmacol Ther. 2013;38:44-51.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 67]  [Cited by in F6Publishing: 72]  [Article Influence: 6.5]  [Reference Citation Analysis (0)]
56.  Lahiff C, Safaie P, Awais A, Akbari M, Gashin L, Sheth S, Lembo A, Leffler D, Moss AC, Cheifetz AS. The Crohn’s disease activity index (CDAI) is similarly elevated in patients with Crohn’s disease and in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2013;37:786-794.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 74]  [Cited by in F6Publishing: 50]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
57.  Abraham BP, Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am. 2012;41:483-495.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 73]  [Cited by in F6Publishing: 76]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
58.  Stryker SJ, Borody TJ, Phillips SF, Kelly KA, Dozois RR, Beart RW. Motility of the small intestine after proctocolectomy and ileal pouch-anal anastomosis. Ann Surg. 1985;201:351-356.  [PubMed]  [DOI]  [Cited in This Article: ]
59.  Pescatori M. Myoelectric and motor activity of the terminal ileum after pelvic pouch for ulcerative colitis. Dis Colon Rectum. 1985;28:246-253.  [PubMed]  [DOI]  [Cited in This Article: ]
60.  Chaussade S, Merite F, Hautefeuille M, Valleur P, Hautefeuille P, Couturier D. Motility of the jejunum after proctocolectomy and ileal pouch anastomosis. Gut. 1989;30:371-375.  [PubMed]  [DOI]  [Cited in This Article: ]
61.  Bassotti G, Castagnoli G, Trancanelli V, Pelli MA, Morelli A. Patients with ileal pouch-anal anastomosis display contractile abnormalities of the reservoir and of the upper ileum. Dig Surg. 1991;8:10-14.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 3]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
62.  Miedema BW, Karlstrom L, Hanson RB, Johnson GP, Kelly KA. Absorption and motility of the bypassed human ileum. Dis Colon Rectum. 1990;33:829-835.  [PubMed]  [DOI]  [Cited in This Article: ]
63.  Summers RW, Anuras S, Green J. Jejunal manometry patterns in health, partial intestinal obstruction, and pseudoobstruction. Gastroenterology. 1983;85:1290-1300.  [PubMed]  [DOI]  [Cited in This Article: ]
64.  Ducrotte P, Koning E, Guillemot F, Guedon C, Lerebours E, Denis P, Colin R. Jejunal motility during cyclic total parenteral nutrition in patients with Crohn’s disease. Gut. 1989;30:815-819.  [PubMed]  [DOI]  [Cited in This Article: ]
65.  Annese V, Bassotti G, Napolitano G, Usai P, Andriulli A, Vantrappen G. Gastrointestinal motility disorders in patients with inactive Crohn’s disease. Scand J Gastroenterol. 1997;32:1107-1117.  [PubMed]  [DOI]  [Cited in This Article: ]
66.  Vrees MD, Pricolo VE, Potenti FM, Cao W. Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines. Arch Surg. 2002;137:439-445; discussion 445-446.  [PubMed]  [DOI]  [Cited in This Article: ]
67.  Neunlist M, Aubert P, Toquet C, Oreshkova T, Barouk J, Lehur PA, Schemann M, Galmiche JP. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut. 2003;52:84-90.  [PubMed]  [DOI]  [Cited in This Article: ]
68.  Cao W, Vrees MD, Kirber MT, Fiocchi C, Pricolo VE. Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol. 2004;286:G833-G843.  [PubMed]  [DOI]  [Cited in This Article: ]
69.  Smith AS, Smid SD. Impaired capsaicin and neurokinin-evoked colonic motility in inflammatory bowel disease. J Gastroenterol Hepatol. 2005;20:697-704.  [PubMed]  [DOI]  [Cited in This Article: ]
70.  La JH, Kim TW, Sung TS, Kang JW, Kim HJ, Yang IS. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J Gastroenterol. 2003;9:2791-2795.  [PubMed]  [DOI]  [Cited in This Article: ]
71.  Verma-Gandhu M, Verdu EF, Bercik P, Blennerhassett PA, Al-Mutawaly N, Ghia JE, Collins SM. Visceral pain perception is determined by the duration of colitis and associated neuropeptide expression in the mouse. Gut. 2007;56:358-364.  [PubMed]  [DOI]  [Cited in This Article: ]
72.  Fukudo S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007;42 Suppl 17:48-51.  [PubMed]  [DOI]  [Cited in This Article: ]
73.  Choi K, Chen J, Mitra S, Sarna SK. Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology. 2011;141:1293-1301, 1301.e1-3.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 22]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
74.  Villanacci V, Antonelli E, Geboes K, Casella G, Bassotti G. Histological healing in inflammatory bowel disease: a still unfulfilled promise. World J Gastroenterol. 2013;19:968-978.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 67]  [Cited by in F6Publishing: 72]  [Article Influence: 6.5]  [Reference Citation Analysis (0)]
75.  Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-Paul MC, Tulic MK, Verhasselt V. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut. 2013;Epub ahead of print.  [PubMed]  [DOI]  [Cited in This Article: ]
76.  Bernardini N, Segnani C, Ippolito C, De Giorgio R, Colucci R, Faussone-Pellegrini MS, Chiarugi M, Campani D, Castagna M, Mattii L. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J Cell Mol Med. 2012;16:318-327.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 66]  [Cited by in F6Publishing: 77]  [Article Influence: 6.4]  [Reference Citation Analysis (0)]
77.  Kern F, Almy TP, Abbot FK, Bogdonoff MD. The motility of the distal colon in nonspecific ulcerative colitis. Gastroenterology. 1951;19:492-503.  [PubMed]  [DOI]  [Cited in This Article: ]
78.  Spriggs EA, Code CF, Bargen JA, Curtiss RK, Hightower NC. Motility of the pelvic colon and rectum of normal persons and patients with ulcerative colitis. Gastroenterology. 1951;19:480-491.  [PubMed]  [DOI]  [Cited in This Article: ]
79.  Connell AM. The motility of the pelvic colon. II. Paradoxical motility in diarrhoea and constipation. Gut. 1962;3:342-348.  [PubMed]  [DOI]  [Cited in This Article: ]
80.  Snape WJ, Matarazzo SA, Cohen S. Abnormal gastrocolonic response in patients with ulcerative colitis. Gut. 1980;21:392-396.  [PubMed]  [DOI]  [Cited in This Article: ]
81.  Reddy SN, Bazzocchi G, Chan S, Akashi K, Villanueva-Meyer J, Yanni G, Mena I, Snape WJ. Colonic motility and transit in health and ulcerative colitis. Gastroenterology. 1991;101:1289-1297.  [PubMed]  [DOI]  [Cited in This Article: ]
82.  Coulie B, Camilleri M, Bharucha AE, Sandborn WJ, Burton D. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol Ther. 2001;15:653-663.  [PubMed]  [DOI]  [Cited in This Article: ]
83.  Bassotti G, de Roberto G, Chistolini F, Sietchiping-Nzepa F, Morelli O, Morelli A. Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions. Int J Colorectal Dis. 2004;19:493-497.  [PubMed]  [DOI]  [Cited in This Article: ]
84.  Bassotti G, Gaburri M, Imbimbo BP, Morelli A, Whitehead WE. Distension-stimulated propagated contractions in human colon. Dig Dis Sci. 1994;39:1955-1960.  [PubMed]  [DOI]  [Cited in This Article: ]
85.  Bassotti G, Villanacci V, Mazzocchi A, Castellani D, Giuliano V, Corsi S, Morelli A. Colonic propulsive and postprandial motor activity in patients with ulcerative colitis in remission. Eur J Gastroenterol Hepatol. 2006;18:507-510.  [PubMed]  [DOI]  [Cited in This Article: ]
86.  Bernstein CN, Niazi N, Robert M, Mertz H, Kodner A, Munakata J, Naliboff B, Mayer EA. Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain. 1996;66:151-161.  [PubMed]  [DOI]  [Cited in This Article: ]
87.  Chrysos E, Athanasakis E, Tsiaoussis J, Zoras O, Nickolopoulos A, Vassilakis JS, Xynos E. Rectoanal motility in Crohn’s disease patients. Dis Colon Rectum. 2001;44:1509-1513.  [PubMed]  [DOI]  [Cited in This Article: ]
88.  Mueller MH, Kreis ME, Gross ML, Becker HD, Zittel TT, Jehle EC. Anorectal functional disorders in the absence of anorectal inflammation in patients with Crohn’s disease. Br J Surg. 2002;89:1027-1031.  [PubMed]  [DOI]  [Cited in This Article: ]
89.  Andersson P, Olaison G, Hallböök O, Boeryd B, Sjödahl R. Increased anal resting pressure and rectal sensitivity in Crohn’s disease. Dis Colon Rectum. 2003;46:1685-1689.  [PubMed]  [DOI]  [Cited in This Article: ]
90.  Kangas E, Hiltunen KM, Matikainen M. Anorectal function in Crohn’s disease. Ann Chir Gynaecol. 1992;81:43-47.  [PubMed]  [DOI]  [Cited in This Article: ]
91.  Buchmann P, Kolb E, Alexander-Williams J. Pathogenesis of urgency in defaecation in Crohn’s disease. Digestion. 1981;22:310-316.  [PubMed]  [DOI]  [Cited in This Article: ]
92.  Keighley MR, Buchmann P, Lee JR. Assessment of anorectal function in selection of patients for ileorectal anastomosis in Crohn’s colitis. Gut. 1982;23:102-107.  [PubMed]  [DOI]  [Cited in This Article: ]
93.  Suzuki H, Fujioka M. Rectal pressure and rectal compliance in ulcerative colitis. Jpn J Surg. 1982;12:79-81.  [PubMed]  [DOI]  [Cited in This Article: ]
94.  Rao SS, Read NW, Davison PA, Bannister JJ, Holdsworth CD. Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis. Gastroenterology. 1987;93:1270-1275.  [PubMed]  [DOI]  [Cited in This Article: ]
95.  Loening-Baucke V, Metcalf AM, Shirazi S. Anorectal manometry in active and quiescent ulcerative colitis. Am J Gastroenterol. 1989;84:892-897.  [PubMed]  [DOI]  [Cited in This Article: ]
96.  Rao SS, Read NW, Stobart JA, Haynes WG, Benjamin S, Holdsworth CD. Anorectal contractility under basal conditions and during rectal infusion of saline in ulcerative colitis. Gut. 1988;29:769-777.  [PubMed]  [DOI]  [Cited in This Article: ]
97.  Arlander E, Löfberg R, Törkvist L, Lindforss U. Exploring anorectal manometry as a method to study the effect of locally administered ropivacaine in patients with ulcerative colitis. ISRN Gastroenterol. 2013;2013:656921.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 4]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
98.  Heppell J, Taylor BM, Beart RW, Dozois RR, Kelly KA. Predicting outcome after endorectal ileoanal anastomosis. Can J Surg. 1983;26:132-134.  [PubMed]  [DOI]  [Cited in This Article: ]
99.  Holdsworth PJ, Sagar PM, Lewis WG, Williamson M, Johnston D. Internal anal sphincter activity after restorative proctocolectomy for ulcerative colitis: a study using continuous ambulatory manometry. Dis Colon Rectum. 1994;37:32-36.  [PubMed]  [DOI]  [Cited in This Article: ]
100.  Saigusa N, Belin BM, Choi HJ, Gervaz P, Efron JE, Weiss EG, Nogueras JJ, Wexner SD. Recovery of the rectoanal inhibitory reflex after restorative proctocolectomy: does it correlate with nocturnal continence? Dis Colon Rectum. 2003;46:168-172.  [PubMed]  [DOI]  [Cited in This Article: ]
101.  Saigusa N, Kurahashi T, Nakamura T, Sugimura H, Baba S, Konno H, Nakamura S. Functional outcome of stapled ileal pouch-anal canal anastomosis versus handsewn pouch-anal anastomosis. Surg Today. 2000;30:575-581.  [PubMed]  [DOI]  [Cited in This Article: ]
102.  Andriesse GI, Gooszen HG, Schipper ME, Akkermans LM, van Vroonhoven TJ, van Laarhoven CJ. Functional results and visceral perception after ileo neo-rectal anastomosis in patients: a pilot study. Gut. 2001;48:683-689.  [PubMed]  [DOI]  [Cited in This Article: ]
103.  Rink AD, Kneist W, Radinski I, Guinot-Barona A, Lang H, Vestweber KH. Differences in ano-neorectal physiology of ileoanal and coloanal reconstructions for restorative proctectomy. Colorectal Dis. 2010;12:342-350.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 16]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
104.  de Zeeuw S, Ahmed Ali U, van der Kolk MB, van Laarhoven KC. Ileal pouch anal anastomosis with close rectal dissection using automated vessel sealers for ulcerative colitis: a promising alternative. Dig Surg. 2011;28:345-351.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 11]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
105.  Kobayashi Y, Iiai T, Yagi M, Okamoto H, Tani T, Hatakeyama K. Postoperative defecatory function of an ileal pouch-anal anastomosis after a restorative proctocolectomy for ulcerative colitis: evaluation using fecoflowmetry. Int Surg. 2011;96:201-206.  [PubMed]  [DOI]  [Cited in This Article: ]
106.  Quigley EM, Bernstein CN. “Irritable bowel symptoms” in inflammatory bowel disease: diagnostic uncertainty meets pathological reality. Am J Gastroenterol. 2012;107:1483-1485.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 8]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
107.  Rijk MC, van Schaik A, van Tongeren JH. Disposition of mesalazine from mesalazine-delivering drugs in patients with inflammatory bowel disease, with and without diarrhoea. Scand J Gastroenterol. 1992;27:863-868.  [PubMed]  [DOI]  [Cited in This Article: ]
108.  Brunner M, Ziegler S, Di Stefano AF, Dehghanyar P, Kletter K, Tschurlovits M, Villa R, Bozzella R, Celasco G, Moro L. Gastrointestinal transit, release and plasma pharmacokinetics of a new oral budesonide formulation. Br J Clin Pharmacol. 2006;61:31-38.  [PubMed]  [DOI]  [Cited in This Article: ]
109.  Lisciandrano D, Benti R, Ranzi T, Baldassarri AR, Bruno A, Bianchi PA, Gerundini P. Scintigraphic imaging and absorption of a 5-aminosalicylic acid enema in patients with ileorectal anastomosis. J Nucl Med. 1999;40:1630-1636.  [PubMed]  [DOI]  [Cited in This Article: ]
110.  Wouters MM, Boeckxstaens GE. Neuroimmune mechanisms in functional bowel disorders. Neth J Med. 2011;69:55-61.  [PubMed]  [DOI]  [Cited in This Article: ]